A Study to Assess the Relative Bioavailability of a New CC-220 Capsule Formulation, Compared to a Reference CC-220 Capsule Formulation, in Healthy Adult Subjects
- First Posted Date
- 2017-05-01
- Last Posted Date
- 2017-07-02
- Lead Sponsor
- Celgene
- Target Recruit Count
- 16
- Registration Number
- NCT03135509
- Locations
- 🇺🇸
Quintiles Phase One Services, LLC, Overland Park, Kansas, United States
A Safety Study of Lenalidomide in Previously Untreated Adult Multiple Myeloma Patients Who Are Not Eligible for Transplant
- First Posted Date
- 2017-04-10
- Last Posted Date
- 2022-06-02
- Lead Sponsor
- Celgene
- Target Recruit Count
- 911
- Registration Number
- NCT03106324
- Locations
- 🇧🇪
AZ Nikolaas, Sint Niklass, Belgium
🇧🇪CHU du Mont-Godinne, Yvoir, Belgium
🇳🇱Nij Smellinghe, Drachten, Netherlands
Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)
- First Posted Date
- 2017-04-04
- Last Posted Date
- 2025-03-30
- Lead Sponsor
- Celgene
- Target Recruit Count
- 1149
- Registration Number
- NCT03098589
- Locations
- 🇯🇵
ASO KK Iizuka Hospital, Iizuka, Fukuoka, Japan
A Study to Assess the Pharmacokinetics of CC-122 in Subjects With Mild, Moderate, and Severe Renal Impairment
- First Posted Date
- 2017-03-31
- Last Posted Date
- 2018-04-26
- Lead Sponsor
- Celgene
- Target Recruit Count
- 48
- Registration Number
- NCT03097016
- Locations
- 🇺🇸
DaVita Clinical Research, Minneapolis, Minnesota, United States
A Study of Durvalumab in Combination With R-CHOP or Lenalidomide Plus R-CHOP in Previously Untreated High-Risk Diffuse Large B-Cell Lymphoma
- Conditions
- Lymphoma, Large B-Cell, Diffuse
- Interventions
- First Posted Date
- 2016-12-28
- Last Posted Date
- 2023-05-22
- Lead Sponsor
- Celgene
- Target Recruit Count
- 46
- Registration Number
- NCT03003520
- Locations
- 🇺🇸
Parkview Research Center, Fort Wayne, Indiana, United States
🇦🇹Hanusch Krankenhaus, Wien, Austria
🇩🇰Odense Universitetshospital, Odense C, Denmark
Use Lenalidomide (Revlimid®) in Combination With Dexamethasone in Clinical Practice for the Treatment of Newly Diagnosed Multiple Myeloma (MM) Transplant Ineligible Patients
- Conditions
- Multiple Myeloma
- First Posted Date
- 2016-12-23
- Last Posted Date
- 2023-06-09
- Lead Sponsor
- Celgene
- Target Recruit Count
- 29
- Registration Number
- NCT03001804
- Locations
- 🇦🇹
Landeskrankenhaus Kirchdorf, Kirchdorf, Austria
🇦🇹Klinikum Klagenfurt am Wörthersee, Klagenfurt, Austria
🇦🇹Ordensklinikum Linz GmbH Elisabethinen, Linz, Austria
A Study to Determine the Efficacy of the Combination of Daratumumab (DARA) Plus Durvalumab (DURVA) (D2) in Subjects With Relapsed and Refractory Multiple Myeloma (RRMM)
- First Posted Date
- 2016-12-22
- Last Posted Date
- 2018-10-16
- Lead Sponsor
- Celgene
- Target Recruit Count
- 18
- Registration Number
- NCT03000452
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸Dana Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸Indiana University Cancer Center, Indianapolis, Indiana, United States
A Single Dose Oral Excretion Balance Study of [14C]-RPC1063 in Healthy Male Adults
- First Posted Date
- 2016-12-15
- Last Posted Date
- 2017-01-27
- Lead Sponsor
- Celgene
- Target Recruit Count
- 6
- Registration Number
- NCT02994381
- Locations
- 🇬🇧
Quotient Clinical, Nottingham, United Kingdom
A Study of Efficacy and Safety of Mongersen (GED-0301) for the Treatment of Adult and Adolescent Subjects With Active Crohn's Disease
- First Posted Date
- 2016-11-28
- Last Posted Date
- 2017-11-14
- Lead Sponsor
- Celgene
- Registration Number
- NCT02974322
- Locations
- 🇺🇸
UMass Medical Center, Worcester, Massachusetts, United States
🇺🇸Henry Ford Health System, Novi, Michigan, United States
🇺🇸High Desert Gastroenterology, Inc., Lancaster, California, United States
A Study to Determine Safety, Feasibility and Efficacy of JCAR015 in Adult Subjects With B-Cell Acute Lymphoblastic Leukemia
- First Posted Date
- 2016-11-25
- Last Posted Date
- 2017-04-10
- Lead Sponsor
- Celgene
- Registration Number
- NCT02973191
- Locations
- 🇮🇹
Azienda Ospedaliera Citta della Salute e della Scienza di Torino, Torino, Italy
🇪🇸ICO-Hospital Germans Trias i Pujol, Barcelona, Spain
🇩🇪Universitaetsklinikum Ulm, Ulm, Germany